Lung Cancer

Our expert lung cancer team works together to care for all types of cancer that affect the lungs and chest, including non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma. We make every effort to ensure that your visits are as convenient as possible. You can often see multiple specialists on the same day, who collaborate to discuss your diagnosis and your entire care plan. You may be eligible to participate in clinical trials, which offer some of the newest therapies available.

Clinical Trials and Research Studies

Phase 1

A Phase 1/1b Open-Label Multi-Center Study to Characterize the Safety and Tolerability of TRQ15-01 in Patients with Relapsed/Refractory Solid Tumors and Lymphomas

Learn More

Phase 3

A PHASE III DOUBLE-BLINDED MULTICENTER RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF NEOADJUVANT TREATMENT WITH ATEZOLIZUMAB OR PLACEBO IN COMBINATION WITH PLATINUM-BASED CHEMOTHERAPY IN PATIENTS WITH RESECTABLE STAGE II IIIA OR SELECT IIIB NON-SMALL CELL LUNG CANCER

Learn More

Phase 1/2

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation

Learn More

Phase 2

A Phase 2 Open-label Multicenter Randomized Multidrug Platform Study of Neoadjuvant Durvalumab Alone or in Combination with Novel Agents in Subjects with Resectable Early-stage (I [> 2 cm] to IIIA) Non-small Cell Lung Cancer (NeoCOAST)

Learn More